Why Do My UTIs Keep Coming Back After Antibiotics?
Antibiotics keep failing because in many women the recurring problem is no longer a simple infection. A 2026 chart review of 253 women referred to a specialty clinic for persistent urogenital symptoms found only about 15% had a classic urologic cause. The rest had hormonal changes at the vaginal opening and pelvic floor, or bacteria embedded where standard urine cultures don't see them. What breaks the cycle is treating that driver: vaginal estrogen after menopause, a pelvic floor and vulvovaginal evaluation when cultures keep coming back negative, and a workup that reaches past another prescription.
The trap is that antibiotics briefly help nearly every time, which makes each round look like a fresh infection. Often it isn't. What's driving the bladder is usually one of a handful of things a course of nitrofurantoin can't fix: an estrogen-depleted vaginal microbiome, a tense pelvic floor, sterile bladder inflammation, or bacteria living inside the bladder wall in a form the standard culture wasn't built to detect. Naming which one it is, for you, is the shift that ends the cycle.
Why the culture keeps coming back inconclusive
In women with recurrent cystitis, the standard midstream culture has a sensitivity of only about 16 to 17%. Biopsies of postmenopausal women with antibiotic-refractory recurrence have shown bacteria living inside the bladder wall even when the urine culture was negative. Those reservoirs don't shed enough into the urine to trip the culture, but they seed the next flare. A negative culture with burning symptoms isn't a mystery. It's a predictable result of a test that wasn't built for this.
When the driver isn't bacterial at all
Interstitial cystitis and bladder pain syndrome produce urgency, frequency, burning, and suprapubic pain through sterile inflammation. Damage to the bladder's inner lining lets urine irritate the wall. Mast cells release mediators that sensitize nerves, the nerves drive further mast cell activation, and the loop sustains itself without infection. Many women describe the pattern starting with a real UTI that never fully resolved. The biology fits: the infection triggered the inflammation, and the inflammation kept running after the bacteria were gone.
The 2026 chart review points at a second driver that gets missed even more often. Hormonally mediated vestibulodynia is pain and irritation at the vaginal opening tied to hormonal shifts, and it can produce urinary burning and urgency that feels exactly like cystitis. In that cohort of 253 women, it was present in 85% of those referred for persistent urogenital symptoms. Pelvic floor hypertonicity was present in 75%. Among the premenopausal women tested, nearly all had low free testosterone. This is a specialty referral population, so the exact fractions won't hold in every primary care setting. The pattern still explains why women who cycle through negative cultures and repeat antibiotics often only get better after a hormonal or pelvic floor evaluation, not a stronger prescription.
Why another antibiotic course rarely fixes it
For a confirmed acute infection, the standard drugs still work most of the time. In a randomized trial, five-day nitrofurantoin cleared symptoms in about 70% of women and single-dose fosfomycin in about 58%, and in a large UK primary care database roughly one in seven women needed a second antibiotic within four weeks regardless of the initial choice. That's acute care working as intended, and it doesn't scale into a strategy for the recurrence pattern.
Long-term suppressive antibiotics reduce infections while you take them and lose the benefit the day you stop. They cost you resistance. In the original placebo-controlled trial of trimethoprim-sulfamethoxazole prophylaxis, trimethoprim resistance in urinary isolates rose to about 67% in treated women versus 33% in controls, and 90% of fecal E. coli became resistant to TMP-SMX within a month. A population-based cohort found women on six or more months of suppressive therapy had higher rates of pyelonephritis and septicemia than women treated only for acute episodes. Cranberry shows a modest signal, roughly a third fewer episodes in meta-analysis of women with a documented recurrence history. Newer oral antibiotics like gepotidacin and pivmecillinam are approved for treating an acute episode, not for stopping the pattern.
What actually breaks the cycle, by driver
The therapies with the best evidence look different depending on what's driving the bladder.
| Likely driver | What the evidence supports | What it doesn't fix |
|---|---|---|
| Postmenopausal genitourinary syndrome | Vaginal estrogen (cream, ring, or tablet); restores lactobacilli and lowers vaginal pH | Pelvic floor tension; non-hormonal bladder inflammation |
| Hormonally mediated vestibulodynia or pelvic floor hypertonicity | Vulvar and pelvic floor exam; pelvic floor physical therapy; hormonal workup where indicated | Antibiotics; vaginal estrogen alone if the pelvic floor is the driver |
| Culture-negative symptoms with suspected intracellular or biofilm bacteria | Expanded or molecular urine testing; specialty referral | Repeat empiric first-line antibiotic courses |
| Confirmed recurrent bacterial cystitis (positive cultures) | Culture-guided targeted antibiotic course; vaginal estrogen if postmenopausal | Long-term suppression that ignores an underlying tissue or hormonal driver |
What to look for before the next prescription
If you're postmenopausal, vaginal estrogen has the strongest evidence of anything in this space. In the placebo-controlled trial by Raz and Stamm, estriol cream cut UTI episodes from about 5.9 to 0.5 per patient-year, roughly a 91% reduction, in 93 women followed over eight months. It works by restoring lactobacilli and lowering vaginal pH, which no antibiotic course can replicate. It needs a prescription, and it's usually the single shift most likely to change your trajectory.
If you're premenopausal with repeatedly negative cultures, the useful next step is a pelvic exam that looks specifically at the vaginal vestibule and pelvic floor. Pelvic floor physical therapy has evidence in hypertonic dysfunction. Vestibulodynia has its own evaluation path that has nothing to do with antibiotics. The 2025 AUA/CUA/SUFU guideline amendment still cautions that PCR and next-generation sequencing don't yet have enough evidence to replace standard culture. For a woman on her fifth failed course, though, it may be the step that finally names the problem.
Recurring bladder symptoms aren't always a recurring infection. If yours keep returning, the step that ends the cycle is usually the one that names and treats what's actually driving the bladder, not another round of the same prescription.